Debiopharm reveals phase 1/2 GaLuCi research results
24th March 2023 Uncategorised 0The multi-centre international clinical trial will evaluate company’s Debio 0328 candidate More: Debiopharm reveals phase 1/2 GaLuCi research results Source: News
read more